sofidexFor patientsAre you a clinician? Clinical site

Meds & supplements  ›  Gatifloxacin

Medicine

Gatifloxacin

ZYMAXID ® is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms: Aerobic gram-positive bacteria: Staphylococcus aureus Staphylococcus epidermidis Streptococcus mitis group *…

Prescribing label

Selected manufacturer label information, organised into consistent sections by Sofidex. This source is written for healthcare professionals; ask your pharmacist to explain instructions that are unclear. Read the full label at DailyMed ↗

Drug facts

Used for
ZYMAXID ® is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms: Aerobic gram-positive bacteria: Staphylococcus aureus Staphylococcus epidermidis Streptococcus mitis group *…
Do not take if
ZYMAXID ® is contraindicated in patients with a history of hypersensitivity to gatifloxacin, to other quinolones, or to any of the components in this medication.

What it is used for

ZYMAXID ® is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms:

  • Aerobic gram-positive bacteria: Staphylococcus aureus Staphylococcus epidermidis Streptococcus mitis group * Streptococcus oralis * Streptococcus pneumoniae
  • Aerobic gram-negative bacteria: Haemophilus influenzae

*Efficacy for these organisms were studied in fewer than 10 infections.

Side effects, and when to stop

The following serious adverse reactions are described elsewhere in the labeling:

  • Hypersensitivity [ see Contraindications ( 4 ) and Warnings and Precautions ( 5.1 ) ]
  • Growth of Resistant Organisms With Prolonged Use [ see Warnings and Precautions ( 5.2 ) ]
  • Corneal Endothelial Cell Injury [ see Warnings and Precautions ( 5.3 ) ]

Who should not take it

ZYMAXID ® is contraindicated in patients with a history of hypersensitivity to gatifloxacin, to other quinolones, or to any of the components in this medication.

2 dosage and administration

  • Day 1: Instill one drop every two hours in the affected eye(s) while awake, up to 8 times.
  • Day 2 through Day 7: Instill one drop two to four times daily in the affected eye(s) while awake.

Cite this page

NLM

sofidex [Internet]. Daloreum; c2026. Gatifloxacin; [reviewed 2026 Aug 2; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/gatifloxacin

APA 7th

sofidex. (2026, August 2). Gatifloxacin. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/gatifloxacin

AMA 11th

Gatifloxacin. sofidex. Reviewed August 2, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/gatifloxacin

The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.